Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer - Top-Institutions - MDSpire

Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer

  • By

  • Han Suk Ryu

  • Amira A. Abdellatef

  • Da Sol Kim

  • Ilias P. Nikas

  • Sergey A. Krupenko

  • May 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Seoul National University Hospital
    Seoul National University Hospital

    Seoul, South Korea

    Key Differentiators

    • Oncology

  • #2

    Cancer and Leukemia Group B
    Cancer and Leukemia Group B

    Chicago, Illinois

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #4

    Vall d’Hebron Institute of Oncology
    Vall d’Hebron Institute of Oncology

    Barcelona, Spain

    Key Differentiators

    • Oncology

Original Source(s)

Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer

  • by Han Suk Ryu, Amira A. Abdellatef, Da Sol Kim, Ilias P. Nikas, Sergey A. Krupenko

  • May 25, 2026

Related Content

How Cancer Online Support Groups Work, for Whom, and in What Circumstances: Realist Review

Correction: Regulatory actions of LH and follicle-stimulating hormone on breast cancer cells and mammary tumors in rats

Management of toxicities from antibody – drug conjugates in breast cancer